CIC's Fund will invest up to £20M per company in later-stage deep tech and life sciences rounds, helping to bridge the UK’s scale-up funding gap.
Some of the key players operating in the market include Thermo Fisher Scientific Inc., Eurofins Scientific, QIAGEN, WuXi AppTec, Promega Corporation, Abcam plc, Merck KGaA, PerkinElmer Inc., Enzo ...
The global miRNA sequencing and assay market size to grow from US$ 391.73 million in 2024, rise to US$ 443.95 million in 2025, and is expected to surpass US$ 1369.11 million by 2034. The market is ...
Cambridge: Aviva Investors and British Patient Capital lead investment into new growth fund addressing the UK’s scale-up ...
Amongst these, Rhian founded a consultancy business to assist investors in the due diligence around technology-based businesses, held marketing and business development roles in biotech companies ...
The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...
Vietnam Investment Review on MSN4d
Understanding the key drivers behind healthcare growth in VietnamSoutheast Asia stands at a pivotal moment in healthcare development. While the region represents 8.5 per cent of the world’s ...
Rising Demand for Genomic Research and Infectious Disease Diagnostics Drives Growth.Pune, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Proteinase K Market Size & Growth Analysis: According to SNS Insider, The ...
The global PD-L1 biomarker testing market is on a strong growth trajectory, rising from USD 777.2 million in 2025 to USD 1,690.8 million by 2035, at a CAGR of 8.1% during the forecast period.PD-L1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback